Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-08-01 5:25 pm Sale | 13D | OPGEN INC PAR $0.01 20 OPGN | Lazar David E. | 10,000 13.000% | -2,480,861 (-99.60%) | View |
2024-04-25 5:43 pm Purchase | 13D | OPGEN INC PAR $0.01 20 OPGN | Lazar David E. | 2,490,861 16.800% | 100,000 (+4.18%) | View |
2024-04-08 4:05 pm Unchanged | 13D | OPGEN INC PAR $0.01 20 OPGN | Lazar David E. | 2,390,861 19.900% | 0 (Unchanged) | View |
2024-04-01 4:05 pm Purchase | 13D | OPGEN INC PAR $0.01 20 OPGN | Lazar David E. | 2,390,861 19.900% | 2,390,861 (New Position) | View |
2020-05-11 2:26 pm Sale | 13D | OPGEN INC PAR $0.01 20 OPGN | Curetis N.V. in Liquidation | 0 0.000% | -1,711,555 (Position Closed) | View |
2020-04-21 8:10 pm Sale | 13D | OPGEN INC PAR $0.01 20 OPGN | Curetis N.V. in Liquidation | 1,711,555 11.650% | -316,653 (-15.61%) | View |
2020-04-13 4:41 pm Purchase | 13D | OPGEN INC PAR $0.01 20 OPGN | Curetis N.V. in Liquidation | 2,028,208 13.800% | 2,028,208 (New Position) | View |
2020-02-10 3:18 pm Unchanged | 13G | OPGEN INC PAR $0.01 20 OPGN | CVI Investments Inc. | 200,000 3.500% | 0 (Unchanged) | View |
2020-01-06 2:42 pm Purchase | 13G | OPGEN INC PAR $0.01 20 OPGN | SABBY MANAGEMENT LLC | 278,555 11.000% | 278,555 (New Position) | View |
2019-11-27 4:06 pm Purchase | 13D | OPGEN INC PAR $0.01 20 OPGN | Merck Global Health Innovation Fund LLC | 24,597 0.440% | 24,597 (New Position) | View |